An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro
- PMID: 12920656
- DOI: 10.1055/s-2003-41355
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro
Abstract
A 52-yr-old woman presented with hypertension, elevated urinary vanillylmandelic acid, metanephrines, normetanephrines, and plasma chromogranin A (CgA), but normal urinary catecholamine levels. Abdominal ultrasonography and subsequent MRI imaging showed a 3 cm nodular lesion of the right adrenal gland also visualized by 123I-meta-iodobenzylguanidine scintigraphy consistent with a pheochromocytoma (PC). Her OctreoScan was negative. The patient underwent right adrenalectomy and histological examination showed a PC. The adrenal medulla tissue was examined for somatostatin (SRIH) receptor subtypes 1 to 5 (SSTR1 to 5) expression by RT-PCR. Cultured tumor cells were treated with either SRIH, Lanreotide (Lan), or an SSTR2 (BIM-23 120) or SSTR5 (BIM-23 206) selective agonist. CgA secretion was measured in the medium by ELISA and catecholamine levels by HPLC after 6h. Cell viability was assessed after 48h. RT-PCR analysis showed that SSTR1, 2, 3 and 4 were expressed. CgA secretion was significantly reduced by SRIH (- 80 %), Lan (- 35 %), and the SSTR2 selective agonist (- 65 %). Norepinephrine secretion was reduced by SRIH (- 66 %), Lan (- 40 %), and BIM-23 120 (- 70 %). Epinephrine and dopamine secretion was also inhibited by treatment with SRIH (- 90 % and - 93 %, respectively) and BIM-23 120 (- 33 % and - 75 %, respectively) but not by Lan. Cell viability was also significantly reduced by SRIH (- 30 %), Lan (- 10 %), and the SSTR2 selective agonist (- 20 %). The SSTR5 selective agonist did not modify either CgA and catecholamine secretion or cell viability. Our data show that SSTRs may be present in a PC although OctreoScan is negative in vivo, and that SRIH and its analogs may reduce both differentiated and proliferative functions in chromaffin cells in vitro. These findings suggest that SRIH analogs with enhanced SSTR2 affinity might be useful in the medical therapy of PC, even when an OctreoScan is negative.
Similar articles
-
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.J Clin Endocrinol Metab. 2006 Jun;91(6):2218-24. doi: 10.1210/jc.2006-0334. Epub 2006 Mar 28. J Clin Endocrinol Metab. 2006. PMID: 16569735
-
Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid.J Clin Endocrinol Metab. 2005 Apr;90(4):2104-9. doi: 10.1210/jc.2004-2156. Epub 2005 Jan 25. J Clin Endocrinol Metab. 2005. PMID: 15671091
-
Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.Neuroendocrinology. 2001 May;73(5):344-51. doi: 10.1159/000054651. Neuroendocrinology. 2001. PMID: 11399907
-
Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.Endocrine. 2003 Apr;20(3):265-9. doi: 10.1385/ENDO:20:3:265. Endocrine. 2003. PMID: 12721506 Review.
-
Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.J Endocrinol Invest. 2005;28(11 Suppl International):36-42. J Endocrinol Invest. 2005. PMID: 16625843 Review.
Cited by
-
Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features.Endocrine. 2014 Apr;45(3):469-78. doi: 10.1007/s12020-013-0007-y. Epub 2013 Jul 2. Endocrine. 2014. PMID: 23817839 Review.
-
Regression of liver metastases of occult carcinoid tumor with slow release lanreotide therapy.World J Gastroenterol. 2005 Apr 7;11(13):2041-4. doi: 10.3748/wjg.v11.i13.2041. World J Gastroenterol. 2005. PMID: 15801004 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials